Martin Evans

Martin Evans

Grundare på
Celixir Plc

Förmögenhet: 2 M $ per 2025-12-31

85 år
Health Technology
Consumer Services

Profil

Martin John Evans is the founder of Oncogeni Ltd. founded in 2019, holding the title of Director since 2022.
Dr. Evans was the founder of Cell Therapy Ltd. founded in 2009, holding the titles of President & Chief Scientific Officer from 2015 to 2018.
Dr. Evans is the founder of Cardiogeni Plc founded in 2016, holding the titles of Director & Chief Scientific Officer since 2016.
Former jobs include Non-Executive Director at Coiled Therapeutics Plc from 2024 to 2025 and President at the University of Cardiff.
Education history includes a doctorate from University College London conferred in 1969 and an undergraduate degree from Christ's College (United Kingdom) conferred in 1963.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
18,92 %
2026-04-21 16 855 254 ( 18,92 % ) 2 M $ 2025-12-31
2024-12-03 269 ( 0 % ) 35 $ 2026-07-31

Aktiva positioner av Martin Evans

FöretagPositionStart
Grundare 2016-12-28
Grundare 2019-05-01

Tidigare kända positioner av Martin Evans

FöretagPositionSlut
ROQT THER Teknisk/Vetenskaplig/F&U Direktör 2024-05-23
President -
Grundare -
Se detaljerna i Martin Evanss erfarenhet

Martin Evanss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

27

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Martin Evans